Quantcast

Latest Biochemical recurrence Stories

2010-11-18 12:48:21

Promising results from first clinical trial A new anti-cancer drug aimed at vitamin D receptors on cancer cells has prompted encouraging responses in the levels of PSA (prostate specific antigen) in men with prostate cancer that has become resistant to hormonal therapies. Results of the phase II(a) clinical trial will be presented at the 22nd EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Berlin today (Thursday). The trial found that when the new drug,...

2010-10-18 17:25:10

A first-ever, long-term study of patients who underwent robot-assisted surgery to remove their cancerous prostates found that nearly 87 percent of them had no recurrence of the disease after five years. The findings were reported in this month's issue of the European Urology journal by a team of Henry Ford Hospital researchers led by Mani Menon, M.D., an internationally recognized pioneer in the use of high-precision surgical robots. In an editorial accompanying the article, the author wrote...

2010-06-29 03:00:46

Men who use statins to lower their cholesterol are 30 percent less likely to see their prostate cancer come back after surgery compared to men who do not use the drugs, according to researchers at Duke University Medical Center. Researchers also found that higher doses of the drugs were associated with lower risk of recurrence. The findings are published in the journal CANCER. "The findings add another layer of evidence suggesting that statins may have an important role in slowing the growth...

2009-12-04 08:07:00

BETHESDA, Md., Dec. 4 /PRNewswire/ -- Drs. Neal Shore and E. David Crawford presented results for prostate-specific antigen (PSA) recurrence from the additional analysis of secondary end points of biochemical recurrence rate in a Phase III pivotal study of FIRMAGON® (monthly degarelix for injection) or monthly leuprolide in prostate cancer patients during the first year of treatment. Prostate cancer patients who received FIRMAGON 240/80 mg/month had a recurrence rate of...

2009-12-02 18:37:39

Prostate cancer patients who have a prostate-specific antigen (PSA) value of less than or equal to 1.5 at two years after external beam radiation therapy (EBRT) are less likely to have a cancer recurrence and cancer-related death, according to a study in the December 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO). PSA levels in a prostate cancer patient are monitored after a patient's...

2009-11-05 12:41:56

Men whose prostate specific antigen (PSA) rise within 18 months of radiotherapy are more likely to develop spread and die of their disease, according to an international study led by Fox Chase Cancer Center radiation oncologist Mark K. Buyyounouski, M.D., M.S. and presented today at the annual meeting of the American Society for Radiation Oncology (ASTRO). "PSA is the gold standard for following prostate cancer patients after they receive radiation or surgery. But we haven't know if having...

2009-10-19 16:31:38

New technology 300 times more sensitive than commercial tests, defines new PSA 'zero' A team of Northwestern University researchers, using an extremely sensitive tool based on nanotechnology, has detected previously undetectable levels of prostate-specific antigen (PSA) in patients who have undergone radical prostatectomy. The researchers found measureable PSA levels in each post-operative patient in its study, thanks to the power of the nanoparticle-based bio-barcode assay developed at...

2009-09-04 15:52:19

Italian researchers suggest using positron emission tomography and computer tomography with choline to detect recurring prostate cancer earlier. The study, published in the Journal of Nuclear Medicine, suggests the scans are quicker than conventional imaging in detecting recurring prostate cancer in those who have had the prostate and surrounding tissue removed. In most patients with biochemical relapse after radical prostatectomy -- prostate removal -- conventional imaging methods often...

2009-09-01 16:41:29

A new study published in the September issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET)/computer tomography (CT) scans with the imaging agent choline could detect recurring prostate cancer sooner than conventional imaging technologies in some patients who have had their prostates surgically removed. In addition, the journal also includes a paper that provides a broader examination of new agents and techniques for imaging prostate cancer, which accounts...

2008-09-19 12:00:36

The American Urological Association is urging U.S. men to decrease their risk of developing prostate cancer by managing their cholesterol. Two separate studies point out an association between cholesterol levels and prostate health risks. In 2007, a retrospective study by the Durham Veteran Affairs Medical Center in North Carolina showed that 1,214 men taking statins to lower their cholesterol also experienced a proportional decline in their levels of prostate-specific antigen, or PSA....


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related